- Bevorzugter Name
- 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
- Englischer Name
- 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
- Summenformel
- C31H39N7O5S
- Molmasse
- 621.76
Namen und Synonyme
Almonertinib mesylateAlmonertinib mesylate, 10 mM in DMSON-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide mesylateN-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide methanesulfonate2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)Almonertinib,EGFR tyrosine kinase inhibitor,Inhibitor,HER1,ErbB-1,third-generation,HS-10296,HS 10296,orally available,Almonertinib mesylate,inhibit,Epidermal growth factor receptor,irreversible,HS10296,non-small cell lung cancer,EGFR
Datenbank-Bezeichner
- PubChem CID
- 162368359
- ChEMBL
CHEMBL5095491- UNII
- RZ6I9WX68U